Cell: Wall cell integrators regulate cancer cell communication to control the cancer burden!
-
Last Update: 2020-06-17
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
, June 9, 2020 /
PRNewswire/ -- An increase in the formation of bio-valley
BIOON /- Blood vessels (BV) is thought to drive tumor growth by increasing nutrient deliveryHowever, this observation ignores the potential role of wall cells in the growth oftumorswithout relying on BV function, researchers from Sun Yat-sen Memorial Hospital at Sun Yat-sen University and the Barts Cancer Institute at Queen Mary University of London, in collaboration with the Journal of Cell, used clinical data and animal experiments to demonstrate that high proportions of wall cell beta-3 integrator-negative tumor BVs are associated with an increase in the size oftumor, but had no effect on the number of BV, the study entitled "Cancer Is SControlled by Cell-Umd 3-Cell-Umin.":Cell
:
BVs-β3;
,-β3
;
-β3FAK-p-HGFR-p-Akt-p-p65;
CCL2MEK1-ROCK2
。 researchers found that in implanted and primary mouse tumor models, the loss of wall cell integrators also promoted the growth of tumor , but had no detectable effects on the number and function of BV At the molecular level, wall cell beta-3 integrator deficiency is enhanced by FAK-p-HGFR-p-Akt-p-p65, which drives the production of CXCL1, CCL2 and TIMP-1 researchers also noted that cCL2 from wall cell sources stimulates signal conduction of tumor cells MEK1-ERK1/2-ROCK2 dependence, improving tumor cell survival and tumor growth overall, the study's data show that wall cells can regulate tumor growth through side secretion signals, which are regulated by beta-3 integrators, providing a previously unknown mechanism for
growth regulation of tumors (BioValleyBioon.com) References: Ping-Pui Wong et al.
Cancer Burden Controll Ised by Mural Cell-beta 3-Integrin Regulated Crosstalk with Cancer Cells Cell 2020.DOI: https://doi.org/10.1016/j.cell.2020.02.003
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.